• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌中非编码区的频繁突变。

Frequent mutation of the untranslated region in prostate cancer.

作者信息

Annala Matti, Taavitsainen Sinja, Vandekerkhove Gillian, Bacon Jack V W, Beja Kevin, Chi Kim N, Nykter Matti, Wyatt Alexander W

机构信息

Faculty of Medicine and Life Sciences and Biomeditech Institute, University of Tampere, FI-33520, Tampere, Finland.

Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V6H 3Z6, Canada.

出版信息

Commun Biol. 2018 Aug 24;1:122. doi: 10.1038/s42003-018-0128-1. eCollection 2018.

DOI:10.1038/s42003-018-0128-1
PMID:30272002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6123809/
Abstract

Prostate cancer has a low somatic mutation rate but non-coding regions remain underexplored. We sequenced the untranslated regions (UTRs) of 72 established driver genes in 428 patients with metastatic prostate cancer and identified 3'-UTR mutations in 12% of patients. The mutations were predominantly insertions or deletions, covered the entire UTR without motif enrichment, and were not detected in other cancers. lies in head-on orientation with the androgen-regulated non-coding gene , resulting in strong prostate lineage-specific bidirectional transcription across the 3'-UTR. This suggests transcriptional activity as a cause for the localized hypermutation. The indel-dominant pattern of somatic mutation extends into the coding region, where it is shaped by clonal selection to yield a cluster of non-frameshift indels inside the forkhead domain. Somatic 3'-UTR mutations may prove useful for diagnostic and screening approaches, given their high frequency and lineage specificity.

摘要

前列腺癌的体细胞突变率较低,但非编码区域仍未得到充分研究。我们对428例转移性前列腺癌患者中72个已确定的驱动基因的非翻译区(UTR)进行了测序,在12%的患者中发现了3'-UTR突变。这些突变主要是插入或缺失,覆盖了整个UTR,没有基序富集,且在其他癌症中未检测到。其与雄激素调节的非编码基因呈头对头方向排列,导致在3'-UTR上出现强烈的前列腺谱系特异性双向转录。这表明转录活性是局部高突变的原因。体细胞突变的插入缺失主导模式延伸到编码区,在那里它受到克隆选择的影响,在叉头结构域内产生一组非移码插入缺失。鉴于其高频率和谱系特异性,体细胞3'-UTR突变可能对诊断和筛查方法有用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d153/6123809/aa06db78c87d/42003_2018_128_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d153/6123809/3214fad995c4/42003_2018_128_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d153/6123809/4f21de092401/42003_2018_128_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d153/6123809/aa06db78c87d/42003_2018_128_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d153/6123809/3214fad995c4/42003_2018_128_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d153/6123809/4f21de092401/42003_2018_128_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d153/6123809/aa06db78c87d/42003_2018_128_Fig3_HTML.jpg

相似文献

1
Frequent mutation of the untranslated region in prostate cancer.前列腺癌中非编码区的频繁突变。
Commun Biol. 2018 Aug 24;1:122. doi: 10.1038/s42003-018-0128-1. eCollection 2018.
2
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.晚期前列腺癌中 FOXA1 激活突变的不同结构类别。
Nature. 2019 Jul;571(7765):413-418. doi: 10.1038/s41586-019-1347-4. Epub 2019 Jun 26.
3
FOXA1 in prostate cancer.FOXA1 在前列腺癌中的作用。
Asian J Androl. 2023 May-Jun;25(3):287-295. doi: 10.4103/aja202259.
4
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.FOXA1 突变改变了启动活性、分化和前列腺癌表型。
Nature. 2019 Jul;571(7765):408-412. doi: 10.1038/s41586-019-1318-9. Epub 2019 Jun 26.
5
The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer.ADRB1(肾上腺素能受体β 1)和 ADRB2 基因与前列腺癌中常见的突变基因显著共表达。
Discov Med. 2020 Nov-Dec;30(161):163-171.
6
Structural and functional analysis of somatic coding and UTR indels in breast and lung cancer genomes.体细胞编码和 UTR 插入缺失在乳腺癌和肺癌基因组中的结构和功能分析。
Sci Rep. 2021 Oct 27;11(1):21178. doi: 10.1038/s41598-021-00583-1.
7
FOXA1 mutations in hormone-dependent cancers.FOXA1 突变与激素依赖性癌症。
Front Oncol. 2013 Feb 14;3:20. doi: 10.3389/fonc.2013.00020. eCollection 2013.
8
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy.在接受根治性前列腺切除术治疗的ERG阴性前列腺癌中,FOXA1表达是早期前列腺特异性抗原(PSA)复发的强有力独立预测指标。
Carcinogenesis. 2017 Dec 7;38(12):1180-1187. doi: 10.1093/carcin/bgx105.
9
Pioneer of prostate cancer: past, present and the future of FOXA1.前列腺癌先驱:FOXA1 的过去、现在和未来。
Protein Cell. 2021 Jan;12(1):29-38. doi: 10.1007/s13238-020-00786-8. Epub 2020 Sep 18.
10
Rarγ -Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.Rarγ - Foxa1信号通路促进前列腺祖细胞的管腔特性,且在前列腺癌中被破坏。
bioRxiv. 2024 Mar 8:2024.03.06.583256. doi: 10.1101/2024.03.06.583256.

引用本文的文献

1
The Germline and Somatic Origins of Prostate Cancer Heterogeneity.前列腺癌异质性的种系和体细胞起源
Cancer Discov. 2025 May 2;15(5):988-1017. doi: 10.1158/2159-8290.CD-23-0882.
2
Integrated machine learning algorithms reveal a bone metastasis-related signature of circulating tumor cells in prostate cancer.集成机器学习算法揭示了前列腺癌循环肿瘤细胞中与骨转移相关的特征。
Sci Data. 2024 Jun 27;11(1):701. doi: 10.1038/s41597-024-03551-2.
3
Lysosome-dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer.

本文引用的文献

1
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.循环肿瘤 DNA 基因组学与前列腺癌对阿比特龙和恩杂鲁胺的耐药性相关。
Cancer Discov. 2018 Apr;8(4):444-457. doi: 10.1158/2159-8290.CD-17-0937. Epub 2018 Jan 24.
2
The Genomics of Prostate Cancer: emerging understanding with technologic advances.前列腺癌的基因组学:技术进步带来的新认识。
Mod Pathol. 2018 Jan;31(S1):S1-11. doi: 10.1038/modpathol.2017.166.
3
Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer.
溶酶体依赖性 FOXA1 泛素化有助于晚期前列腺癌的管腔谱系。
Mol Oncol. 2023 Oct;17(10):2126-2146. doi: 10.1002/1878-0261.13497. Epub 2023 Aug 21.
4
FOXA1 in prostate cancer.FOXA1 在前列腺癌中的作用。
Asian J Androl. 2023 May-Jun;25(3):287-295. doi: 10.4103/aja202259.
5
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.原发性前列腺癌与配对转移灶的比较基因组学:12 个分子病例研究的见解。
J Pathol. 2022 Jul;257(3):274-284. doi: 10.1002/path.5887. Epub 2022 Mar 28.
6
Predicting master transcription factors from pan-cancer expression data.从泛癌表达数据中预测主转录因子。
Sci Adv. 2021 Nov 26;7(48):eabf6123. doi: 10.1126/sciadv.abf6123. Epub 2021 Nov 24.
7
Circulating Cell-Free DNA-Based Detection of Tumor Suppressor Gene Copy Number Loss and Its Clinical Implication in Metastatic Prostate Cancer.基于循环游离DNA检测肿瘤抑制基因拷贝数缺失及其在转移性前列腺癌中的临床意义
Front Oncol. 2021 Aug 24;11:720727. doi: 10.3389/fonc.2021.720727. eCollection 2021.
8
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer.血浆 ctDNA 是肿瘤组织的替代物,可实现转移性膀胱癌的临床基因组分层。
Nat Commun. 2021 Jan 8;12(1):184. doi: 10.1038/s41467-020-20493-6.
9
Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research.前列腺癌的细胞与分子进展:基础研究和临床前研究模型
Cancers (Basel). 2020 Sep 17;12(9):2651. doi: 10.3390/cancers12092651.
10
Pioneer of prostate cancer: past, present and the future of FOXA1.前列腺癌先驱:FOXA1 的过去、现在和未来。
Protein Cell. 2021 Jan;12(1):29-38. doi: 10.1007/s13238-020-00786-8. Epub 2020 Sep 18.
全转录组分析天然反义转录本表明它们在乳腺癌中的潜在作用。
Sci Rep. 2017 Dec 12;7(1):17452. doi: 10.1038/s41598-017-17811-2.
4
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.前列腺癌中循环肿瘤DNA与配对转移组织活检的一致性
J Natl Cancer Inst. 2017 Dec 1;109(12). doi: 10.1093/jnci/djx118.
5
Transcribing malignancy: transcription-associated genomic instability in cancer.转录致瘤:癌症中与转录相关的基因组不稳定性。
Oncogene. 2018 Feb 22;37(8):971-981. doi: 10.1038/onc.2017.402. Epub 2017 Nov 6.
6
Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy.新辅助多西他赛和雄激素剥夺治疗高危前列腺癌的基因组学和转录组学治疗影响。
Clin Cancer Res. 2017 Nov 15;23(22):6802-6811. doi: 10.1158/1078-0432.CCR-17-1034. Epub 2017 Aug 25.
7
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer.循环肿瘤 DNA 揭示转移性膀胱癌的临床可操作体细胞基因组。
Clin Cancer Res. 2017 Nov 1;23(21):6487-6497. doi: 10.1158/1078-0432.CCR-17-1140. Epub 2017 Jul 31.
8
Recurrent and functional regulatory mutations in breast cancer.乳腺癌中的复发性和功能性调控突变。
Nature. 2017 Jul 6;547(7661):55-60. doi: 10.1038/nature22992. Epub 2017 Jun 28.
9
Insertions and Deletions Target Lineage-Defining Genes in Human Cancers.插入和缺失靶向人类癌症中的谱系定义基因。
Cell. 2017 Jan 26;168(3):460-472.e14. doi: 10.1016/j.cell.2016.12.025. Epub 2017 Jan 12.
10
Genomic hallmarks of localized, non-indolent prostate cancer.局限性、非惰性前列腺癌的基因组特征。
Nature. 2017 Jan 19;541(7637):359-364. doi: 10.1038/nature20788. Epub 2017 Jan 9.